Skip to search.
 TSX Up 0.03% TSX Ventures Up 1.56%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
95.20 Up 0.23(0.24%) 9:40AM EDT - Nasdaq Real Time Price
Prev Close:94.97
Open:N/A
Bid:94.50 x 100
Ask:95.49 x 100
1y Target Est:119.29
Beta:1.65374
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:94.57 - 95.56
52wk Range:62.12 - 136.85
Volume:46,959
Avg Vol (3m):1,919,380
Market Cap:16.26B
P/E (ttm):N/A
EPS (ttm):-3.29
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BMRNUp 0.24%16.26B
FOLDUp 0.43%996.39M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.94
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-3.96
Quarterly EPS Est (Sep-16) :-0.39
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-1.00

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback